Investments, Funding & Disinvestment

The partnership aligns with Africa CDC’s Health Security and Sovereignty Agenda, which seeks to help African countries build stronger systems that can prevent, detect, and respond to disease threats while reducing reliance on external support.

The collaboration will enhance the company’s ability to analyze complex datasets, identify promising drug candidates, and significantly reduce the time required to bring medications to patients.

Peak XV Partners leads investment round, with participation from Define Ventures and previous backers.

Biovac will construct the new facility at its Cape Town manufacturing site, with completion expected by 2028.

The acquisition will see Saga integrated into Roche’s subsidiary, Foundation Medicine, which focuses on advanced genomic profiling and personalised cancer care.

By integrating Aicuris into its global development and commercialization infrastructure, Asahi Kasei accelerates its expansion in the specialty pharmaceutical sector.

The updated platform now connects customers with companies such as Twin Health, Curai Health, Wheel, Berry Street, and Aaptiv.

MyGenius PRO adds to Bruker’s molecular diagnostics portfolio, which includes InGenius, BeGenius, and LiquidArray assays.

Exhibitors will present a wide range of medical technologies and products, including surgical equipment, diagnostic systems, and pharmaceutical solutions.

The agreement also includes potential clinical, regulatory, and commercial milestone payments that could raise the total value to USD7 billion,